Bio-Rad Laboratories Inc
Uždarymo kaina
SektoriusSveikatos priežiūra
278.8 2.85
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
269.92
Max
283.35
Pajamos | -731M -11M |
|---|---|
Pardavimai | -101M 592M |
P/E Sektoriaus vid. | 48.213 49.712 |
Pelnas, tenkantis vienai akcijai | 1.89 |
Pelno marža | -1.858 |
Darbuotojai | 7,450 |
EBITDA | -751M -637M |
Rekomendacijos | Neutralu |
|---|---|
12 mėnesių prognozė | +11.44% upside |
Kitas uždarbis | 2026-07-30 |
|---|
Rinkos kapitalizacija | -16M 7.7B |
|---|---|
Ankstesnė atidarymo kaina | 275.95 |
Ankstesnė uždarymo kaina | 278.8 |
Naujienos nuotaikos
By Acuity
50%
50%
143 / 342 reitingas Healthcare
Bio-Rad Laboratories Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.